Day: August 2, 2021

Results for the Second Quarter of 2021:Net income attributable to the company of $9.7 million, or $0.20 per diluted share inclusive of a $3.8 million loss related to the sale of certain assets and a $9.5 million charge related to a private exchange of convertible notes Adjusted EBITDA of $54.8 million, exclusive of a $3.8 million loss related to the sale of certain assets Consolidated crush margin of $0.37 per gallon Strong liquidity position, with cash, cash equivalents and restricted cash of $615.4 million and $294.2 million available under committed credit facilitiesOMAHA, Neb., Aug. 02, 2021 (GLOBE NEWSWIRE) — Green Plains Inc. (NASDAQ:GPRE) today announced financial results for the second quarter of 2021. Net income attributable to the company was $9.7 million, or $0.20 per diluted share inclusive of a loss related to...

Results show that every six-week natalizumab IV administration provides a high level of efficacy in controlling MS disease activity in patients who switched from the approved every four-week dosing regimen Data from the first prospective, randomized, controlled study of an extended dosing schedule for natalizumab offer valuable insights and build on positive real-world effectiveness findings1,2,3 Updated analyses from the TOUCH® Prescribing Program indicate an average six-week dosing schedule is associated with an 88 percent reduction in the probability of developing PML4CAMBRIDGE, Mass., Aug. 02, 2021 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced results from the two-year prospective, randomized, interventional, controlled, open-label Phase 3b NOVA study (NCT03689972). NOVA was designed to estimate a potential...

FREMONT, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) — Enovix Corporation (“Enovix”) (Nasdaq: ENVX, ENVXW), the leader in the design and manufacture of next generation 3D Silicon™ Lithium-ion batteries, today announced that the management team will present at the Oppenheimer 24th Annual Technology, Internet & Communications Conference on Wednesday, August 11, 2021 at 4:35 PM Eastern Time. You can access the webcast of the presentation from the News and Events section of Enovix’s website at https://ir.enovix.com. About Enovix Enovix is the leader in advanced silicon-anode lithium-ion battery development and production. The company’s proprietary 3D cell architecture increases energy density and maintains high cycle life. Enovix is building an advanced silicon-anode lithium-ion battery production facility in the U.S. for...

WASHINGTON, Aug. 02, 2021 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that Global Arbitration Review (“GAR”) has recognized the Company and its Compass Lexecon subsidiary as top expert witness firms in its annual GAR 100 Expert Witness Firms’ Power Index. FTI Consulting ranked first overall, and Compass Lexecon ranked second. FTI Consulting and Compass Lexecon had a combined 23 Thought Leaders, experts who placed in the top 2% of Who’s Who Legal research. The next closest firm had six Thought Leaders. According to GAR’s analysis, FTI Consulting had 223 experts attend hearings between August 2018 and August 2020, almost three times the next firm. FTI Consulting had the most construction-related arbitrations of any firm, with 88. Compass Lexecon led all firms in investor-state hearings, with 39. In a new table...

Rogers, Arkansas , Aug. 02, 2021 (GLOBE NEWSWIRE) — America’s Car-Mart, one of the largest publicly-held automotive retailers in the “Integrated Auto Sales and Finance” segment of the used car market, is commemorating its 40th year in business. In 1981, Car-Mart set out a vision to help credit-challenged customers find a vehicle that makes a difference in their lives. For 40 years, the Company has provided transportation solutions and legendary service to customers and local communities. In August 1981, founder Bill Fleeman opened the first Car-Mart in a converted Dog n’ Suds fast food operation in Rogers, Arkansas. That store featured quality, used vehicles and flexible financing. Mr. Fleeman’s purpose was to provide a good value for the customers’ money. Now with over 2,000 associates, 151 dealerships in 12 states and over...

CENTREVILLE, Va., Aug. 02, 2021 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) has won a prime position on the General Services Administration‘s (GSA) multiple-award ASTRO indefinite-delivery/indefinite-quantity (ID/IQ) contract. The contract has a potential value in the multi-billions with no defined ceiling value and a 10-year ordering period. The new contract is being administered through GSA’s Federal Systems Integration and Management Center (FEDSIM). It focuses on providing innovative, future technology, products, solutions, and capabilities to the Department of Defense across the all-domain battlespace. Parsons was selected for six pools: ground, space, development and integration, research, support, and training. “Parsons’ breadth of combat-proven all-domain solutions, artificial intelligence and machine learning technology,...

WALTHAM, Mass., Aug. 02, 2021 (GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today reported key business updates and financial results for the quarter ended June 30, 2021. Roluperidone Update Following the completion of the open-label portion of the Phase 3 trial with roluperidone in schizophrenia and the Type C meeting with the U.S. Food and Drug Administration (FDA), the Company continues to work towards the submission of a New Drug Application (NDA) in the first half of 2022. On June 29, 2021, the Company completed the enrollment of 48 subjects in a pivotal bioequivalence study with roluperidone in healthy volunteers. The objective of this study is to compare the formulations employed...

Ms. Lynch will lead ongoing building and implementation of ReWalk’s market access and reimbursement programs MARLBOROUGH, Mass., Aug. 02, 2021 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced Jeannine Lynch will join the Company on August 31, 2021, as Vice President of Strategy and Market Access. Ms. Lynch will focus on completing the building and implementation of ReWalk’s market access and reimbursement programs. Ms. Lynch will report to ReWalk CEO, Larry Jasinski. She will also be part of the management team responsible for overseeing planning and implementation of all company business strategy and policies. “We have been the worldwide leader in building payment pathways and coverage for...

Company to ramp up marketing efforts for Provista’s automated capabilities for COVID-19 PCR testing, variant identification, and neutralizing antibody testing NEW YORK, NY, and TEL AVIV, ISRAEL, Aug. 02, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that it has made the final payment of $1.25 million to complete its $10 million acquisition of Provista Diagnostics, Inc. Provista is a medical diagnostics company based in Alpharetta, Georgia that owns the intellectual property rights to the proprietary breast cancer blood test, Videssa®, and has a diagnostic testing laboratory currently performing COVID-19 PCR testing, primarily for the medical and entertainment industries.  Over $50 million in research and development...

Results for the Second Quarter of 2021Net income of $10.3 million, or $0.44 per common unit Adjusted EBITDA of $12.7 million and distributable cash flow of $11.2 million Quarterly cash distribution of $0.12 per unit Distribution coverage ratio of 3.95x, LTM distribution coverage ratio of 4.01xOMAHA, Neb., Aug. 02, 2021 (GLOBE NEWSWIRE) — Green Plains Partners LP (NASDAQ:GPP) today announced financial and operating results for the second quarter of 2021. Net income attributable to the partnership was $10.3 million, or $0.44 per common unit, for the second quarter of 2021 compared with net income of $10.2 million, or $0.43 per common unit, for the same period in 2020. The partnership also reported adjusted EBITDA of $12.7 million and distributable cash flow of $11.2 million for the second quarter of 2021, compared with adjusted...